BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev 2013;24:203-15. [PMID: 23684423 DOI: 10.1016/j.cytogfr.2013.04.003] [Cited by in Crossref: 223] [Cited by in F6Publishing: 209] [Article Influence: 24.8] [Reference Citation Analysis]
Number Citing Articles
1 Tesar V, Hruskova Z. Belimumab in the management of systemic lupus erythematosus – an update. Expert Opinion on Biological Therapy 2017;17:901-8. [DOI: 10.1080/14712598.2017.1324846] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
2 Schwarting A, Relle M, Meineck M, Föhr B, Triantafyllias K, Weinmann A, Roth W, Weinmann-Menke J. Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men. Lupus 2018;27:243-56. [PMID: 28659046 DOI: 10.1177/0961203317717083] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
3 Chen J, He D, Chen Q, Guo X, Yang L, Lin X, Li Y, Wu W, Yang Y, He J, Zhang E, Yi Q, Cai Z. BAFF is involved in macrophage-induced bortezomib resistance in myeloma. Cell Death Dis 2017;8:e3161. [PMID: 29095438 DOI: 10.1038/cddis.2017.533] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
4 Yu TS, Wang HY, Zhao YJ, Yu YF, Hou Y, Liu S, Han PP, Ni XF, Ji XB, Peng J, Liu XG, Hou M. Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia. Blood Adv 2021;5:4087-101. [PMID: 34507351 DOI: 10.1182/bloodadvances.2020003860] [Reference Citation Analysis]
5 Ratajczak-Wrona W, Wawrusiewicz-Kurylonek N, Garley M, Kretowski AJ, Jablonska E. A Proliferation-Inducing Ligand Regulation in Polymorphonuclear Neutrophils by Panax ginseng. Arch Immunol Ther Exp (Warsz) 2020;68:32. [PMID: 33125603 DOI: 10.1007/s00005-020-00597-z] [Reference Citation Analysis]
6 Uzawa A, Kuwabara S, Suzuki S, Imai T, Murai H, Ozawa Y, Yasuda M, Nagane Y, Utsugisawa K. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clin Exp Immunol 2021;203:366-74. [PMID: 33184844 DOI: 10.1111/cei.13546] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gommerman JL, Rojas OL, Fritz JH. Re-thinking the functions of IgA(+) plasma cells. Gut Microbes 2014;5:652-62. [PMID: 25483334 DOI: 10.4161/19490976.2014.969977] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 9.7] [Reference Citation Analysis]
8 Milo R. Therapies for multiple sclerosis targeting B cells. Croat Med J 2019;60:87-98. [PMID: 31044580 [PMID: 31044580 DOI: 10.3325/cmj.2019.60.87] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
9 Pott MC, Frede N, Wanders J, Hammarström L, Glocker EO, Glocker C, Tahami F, Grimbacher B. Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibody-deficiencies? BMC Immunol 2017;18:34. [PMID: 28651547 DOI: 10.1186/s12865-017-0217-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
10 Chang CM, Wu PC, Lin JR, Jan Wu YJ, Luo SF, Hsue YT, Lan JL, Pan TL, Wu YT, Yu KH, Wei YH, Chang HH. Herbal Formula SS-1 Increases Tear Secretion for Sjögren's Syndrome. Front Pharmacol 2021;12:645437. [PMID: 34630072 DOI: 10.3389/fphar.2021.645437] [Reference Citation Analysis]
11 Vincent FB, Morand EF, Schneider P, Mackay F. The BAFF/APRIL system in SLE pathogenesis. Nat Rev Rheumatol 2014;10:365-73. [PMID: 24614588 DOI: 10.1038/nrrheum.2014.33] [Cited by in Crossref: 227] [Cited by in F6Publishing: 208] [Article Influence: 28.4] [Reference Citation Analysis]
12 Varzaneh FN, Keller B, Unger S, Aghamohammadi A, Warnatz K, Rezaei N. Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge. J Clin Immunol 2014;34:524-43. [PMID: 24827633 DOI: 10.1007/s10875-014-0053-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
13 Wallden M, Nijs J. Applying the understanding of central sensitization in practice. J Bodyw Mov Ther 2021;27:723-30. [PMID: 34391313 DOI: 10.1016/j.jbmt.2021.04.004] [Reference Citation Analysis]
14 Zhang Y, Li J, Zhou N, Zhang Y, Wu M, Xu J, Shen C, An X, Shen G, Yang M, Zhang C, Tao J. The Unknown Aspect of BAFF: Inducing IL-35 Production by a CD5+CD1dhiFcγRIIbhi Regulatory B-Cell Subset in Lupus. Journal of Investigative Dermatology 2017;137:2532-43. [DOI: 10.1016/j.jid.2017.07.843] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
15 Thoreau B, Chaigne B, Mouthon L. Role of B-Cell in the Pathogenesis of Systemic Sclerosis. Front Immunol 2022;13:933468. [DOI: 10.3389/fimmu.2022.933468] [Reference Citation Analysis]
16 King A, Li L, Wong DM, Liu R, Bamford R, Strasser A, Tarlinton DM, Heierhorst J. Dynein light chain regulates adaptive and innate B cell development by distinctive genetic mechanisms. PLoS Genet 2017;13:e1007010. [PMID: 28922373 DOI: 10.1371/journal.pgen.1007010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
17 Morais SA, Vilas-Boas A, Isenberg DA. B-cell survival factors in autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis 2015;7:122-51. [PMID: 26288664 DOI: 10.1177/1759720X15586782] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
18 Li XY, Duan HJ, Liu XY, Deng XL. Change of serum B-cell activating factor level in patients with positive antiphospholipid antibodies and previous adverse pregnancy outcomes and its significance. Chin Med J (Engl) 2020;133:2287-94. [PMID: 32842014 DOI: 10.1097/CM9.0000000000000948] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Alexander-Miller MA. Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges. J Immunol 2014;193:5363-9. [PMID: 25411431 DOI: 10.4049/jimmunol.1401410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
20 Poudrier J, Soulas C, Chagnon-Choquet J, Burdo T, Autissier P, Oskar K, Williams KC, Roger M. High expression levels of BLyS/BAFF by blood dendritic cells and granulocytes are associated with B-cell dysregulation in SIV-infected rhesus macaques. PLoS One 2015;10:e0131513. [PMID: 26107380 DOI: 10.1371/journal.pone.0131513] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
21 Ntellas P, Dardiotis E, Sevdali E, Siokas V, Aloizou AM, Tsinti G, Germenis AE, Hadjigeorgiou GM, Eibel H, Speletas M. TNFRSF13C/BAFFR P21R and H159Y polymorphisms in multiple sclerosis. Mult Scler Relat Disord 2020;37:101422. [PMID: 32172995 DOI: 10.1016/j.msard.2019.101422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Giordano D, Kuley R, Draves KE, Roe K, Holder U, Giltiay NV, Clark EA. BAFF Produced by Neutrophils and Dendritic Cells Is Regulated Differently and Has Distinct Roles in Antibody Responses and Protective Immunity against West Nile Virus. J Immunol 2020;204:1508-20. [PMID: 32034064 DOI: 10.4049/jimmunol.1901120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Mueller AL, Payandeh Z, Mohammadkhani N, Mubarak SMH, Zakeri A, Alagheband Bahrami A, Brockmueller A, Shakibaei M. Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies. Cells 2021;10:3017. [PMID: 34831240 DOI: 10.3390/cells10113017] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ortiz-Aljaro P, Montes-Cano MA, García-Lozano JR, Aquino V, Carmona R, Perez-Florido J, García-Hernández FJ, Dopazo J, González-Escribano MF. Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus. Sci Rep 2022;12:11219. [PMID: 35780200 DOI: 10.1038/s41598-022-15549-0] [Reference Citation Analysis]
25 Bolkun L, Lemancewicz D, Jablonska E, Szumowska A, Bolkun-Skornicka U, Ratajczak-Wrona W, Dzieciol J, Kloczko J. The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features. Ann Hematol 2015;94:35-43. [PMID: 25085377 DOI: 10.1007/s00277-014-2178-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
26 Lenert A, Lenert P. Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents. Drug Des Devel Ther 2015;9:333-47. [PMID: 25609919 DOI: 10.2147/DDDT.S67264] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
27 Uzawa A, Kanai T, Kawaguchi N, Oda F, Himuro K, Kuwabara S. Changes in inflammatory cytokine networks in myasthenia gravis. Sci Rep 2016;6:25886. [PMID: 27172995 DOI: 10.1038/srep25886] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
28 Low M, Infantino S, Grigoriadis G, Tarlinton D. Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells? Immunol Rev 2016;270:78-94. [DOI: 10.1111/imr.12388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
29 Uzzan M, Colombel JF, Cerutti A, Treton X, Mehandru S. B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. Dig Dis Sci 2016;61:3407-24. [PMID: 27655102 DOI: 10.1007/s10620-016-4317-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
30 Zhang H, Chambers W, Sciascia S, Cuadrado MJ. Emerging therapies in systemic lupus erythematous: from clinical trial to the real life. Expert Review of Clinical Pharmacology 2016;9:681-94. [DOI: 10.1586/17512433.2016.1155446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Samitas K, Malmhäll C, Rådinger M, Ramos-Ramirez P, Lu Y, Deák T, Semitekolou M, Gaga M, Sjöstrand M, Lötvall J, Bossios A. Precursor B Cells Increase in the Lung during Airway Allergic Inflammation: A Role for B Cell-Activating Factor. PLoS One 2016;11:e0161161. [PMID: 27513955 DOI: 10.1371/journal.pone.0161161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
32 Hoffman W, Lakkis FG, Chalasani G. B Cells, Antibodies, and More. Clin J Am Soc Nephrol 2016;11:137-54. [PMID: 26700440 DOI: 10.2215/CJN.09430915] [Cited by in Crossref: 158] [Cited by in F6Publishing: 85] [Article Influence: 22.6] [Reference Citation Analysis]
33 Yao X, Li C, Yang J, Wang G, Li C, Xia Y. Differences in frequency and regulation of T follicular helper cells between newly diagnosed and chronic pediatric immune thrombocytopenia. Blood Cells, Molecules, and Diseases 2016;61:26-36. [DOI: 10.1016/j.bcmd.2016.06.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
34 Robinson RR, Dietz AK, Maroof AM, Asmis R, Forsthuber TG. The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain. Immunotherapy 2019;11:129-47. [PMID: 30730270 DOI: 10.2217/imt-2018-0153] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
35 Badr MT, Häcker G. Gene expression profiling meta-analysis reveals novel gene signatures and pathways shared between tuberculosis and rheumatoid arthritis. PLoS One 2019;14:e0213470. [PMID: 30845171 DOI: 10.1371/journal.pone.0213470] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
36 Chang Y, Sun X, Jia X, Xu S, Wei F, Yang X, Wei W. Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis. International Immunopharmacology 2015;24:451-7. [DOI: 10.1016/j.intimp.2015.01.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
37 Lee SJ, Oh HJ, Choi BY, Jang YJ, Lee JY, Park JK, Song YW. Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren's Syndrome. J Immunol Res 2016;2016:5781070. [PMID: 28074193 DOI: 10.1155/2016/5781070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
38 Dong Z, Liu Z, Dai H, Liu W, Feng Z, Zhao Q, Gao Y, Liu F, Zhang N, Dong X, Zhou X, Du J, Huang G, Tian X, Liu B. The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy. J Immunol Res 2020;2020:7638365. [PMID: 33426094 DOI: 10.1155/2020/7638365] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 ‘t Hart BA, Jagessar SA, Kap YS, Haanstra KG, Philippens IH, Serguera C, Langermans J, Vierboom M. Improvement of preclinical animal models for autoimmune-mediated disorders via reverse translation of failed therapies. Drug Discovery Today 2014;19:1394-401. [DOI: 10.1016/j.drudis.2014.03.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
40 Duan L, Chen L, Zhong S, Wang Y, Huang Y, He Y, Chen J, Shi G. Treatment of Bullous Systemic Lupus Erythematosus. J Immunol Res 2015;2015:167064. [PMID: 26090480 DOI: 10.1155/2015/167064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
41 Martín‐penagos L, Benito‐hernández A, San Segundo D, Sango C, Azueta A, Gómez‐román J, Fernández‐fresnedo G, López‐hoyos M, Ruiz JC, Rodrigo E. A proliferation‐inducing ligand increase precedes IgA nephropathy recurrence in kidney transplant recipients. Clin Transplant 2019;33:e13502. [DOI: 10.1111/ctr.13502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
42 Ahmed AR, Nguyen T, Kaveri S, Spigelman ZS. First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up. International Immunopharmacology 2016;34:25-31. [DOI: 10.1016/j.intimp.2016.02.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
43 Li L, He J, Zhu L, Yang Y, Jin Y, Jia R, Liu X, Liu Y, Sun X, Li Z. The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome. J Immunol Res 2015;2015:307453. [PMID: 26436101 DOI: 10.1155/2015/307453] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
44 Vincent FB, Kandane-Rathnayake R, Hoi AY, Slavin L, Godsell JD, Kitching AR, Harris J, Nelson CL, Jenkins AJ, Chrysostomou A, Hibbs ML, Kerr PG, Rischmueller M, Mackay F, Morand EF. Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus. Lupus 2018;27:2029-40. [PMID: 30301439 DOI: 10.1177/0961203318804885] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
45 Schuh E, Musumeci A, Thaler FS, Laurent S, Ellwart JW, Hohlfeld R, Krug A, Meinl E. Human Plasmacytoid Dendritic Cells Display and Shed B Cell Maturation Antigen upon TLR Engagement. J I 2017;198:3081-8. [DOI: 10.4049/jimmunol.1601746] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
46 Seikrit C, Rauen T, Stamellou E, Floege J. Precision medicine in immunoglobulin A nephropathy: still a journey ahead. Nephrol Dial Transplant 2021;36:24-30. [PMID: 34153983 DOI: 10.1093/ndt/gfab032] [Reference Citation Analysis]
47 Magliozzi R, Marastoni D, Calabrese M. The BAFF / APRIL system as therapeutic target in multiple sclerosis. Expert Opin Ther Targets 2020;24:1135-45. [PMID: 32900236 DOI: 10.1080/14728222.2020.1821647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
48 Friebus-kardash J, Branco L, Ribi C, Chizzolini C, Huynh-do U, Dubler D, Roux-lombard P, Dolff S, Kribben A, Eisenberger U, Trendelenburg M. Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus. Nephrology Dialysis Transplantation 2018;33:54-64. [DOI: 10.1093/ndt/gfx220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
49 Alturaiki W, Mubarak A, Mir SA, Afridi A, Premanathan M, Mickymaray S, Vijayakumar R, Alsagaby SA, Almalki SG, Alghofaili F, Alnemare AK, Flanagan BF. Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia. Saudi J Biol Sci 2021;28:7455-9. [PMID: 34867050 DOI: 10.1016/j.sjbs.2021.08.044] [Reference Citation Analysis]
50 Carrillo-Ballesteros FJ, Oregon-Romero E, Franco-Topete RA, Govea-Camacho LH, Cruz A, Muñoz-Valle JF, Bustos-Rodríguez FJ, Pereira-Suárez AL, Palafox-Sánchez CA. B-cell activating factor receptor expression is associated with germinal center B-cell maintenance. Exp Ther Med 2019;17:2053-60. [PMID: 30783477 DOI: 10.3892/etm.2019.7172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
51 Dooley J, Pauwels I, Franckaert D, Smets I, Garcia-Perez JE, Hilven K, Danso-Abeam D, Terbeek J, Nguyen AT, De Muynck L, Decallonne B, Dubois B, Liston A, Goris A. Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations. Neurol Neuroimmunol Neuroinflamm 2016;3:e240. [PMID: 27231713 DOI: 10.1212/NXI.0000000000000240] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
52 Cen SY, Moreau JM, Furlonger C, Berger A, Paige CJ. Differential regulation of IgA+ B cells in vitro by stromal cells from distinctive anatomical compartments. J Leukoc Biol 2019;105:507-18. [PMID: 30576006 DOI: 10.1002/JLB.1A0517-172RR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
53 Negron A, Robinson RR, Stüve O, Forsthuber TG. The role of B cells in multiple sclerosis: Current and future therapies. Cell Immunol 2019;339:10-23. [PMID: 31130183 DOI: 10.1016/j.cellimm.2018.10.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
54 Li G, Zhang Q, Liu Z, Shen H, Zhu Y, Zhou Z, Ding W, Han S, Zhou J, Ou R, Luo M, Liu S. TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss. Cancer Cell Int 2021;21:223. [PMID: 33865370 DOI: 10.1186/s12935-021-01923-x] [Reference Citation Analysis]
55 Stohl W. Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 2014;18:473-89. [DOI: 10.1517/14728222.2014.888415] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
56 Pinna RA, Dos Santos AC, Perce-da-Silva DS, da Silva LA, da Silva RNR, Alves MR, Santos F, de Oliveira Ferreira J, Lima-Junior JC, Villa-Verde DM, De Luca PM, Carvalho-Pinto CE, Banic DM. Correlation of APRIL with production of inflammatory cytokines during acute malaria in the Brazilian Amazon. Immun Inflamm Dis 2018;6:207-20. [PMID: 29314720 DOI: 10.1002/iid3.208] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
57 Thanou A, Jupe E, Purushothaman M, Niewold TB, Munroe ME. Clinical disease activity and flare in SLE: Current concepts and novel biomarkers. J Autoimmun 2021;119:102615. [PMID: 33631651 DOI: 10.1016/j.jaut.2021.102615] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Su Z, Wu Y. A Systematic Test of Receptor Binding Kinetics for Ligands in Tumor Necrosis Factor Superfamily by Computational Simulations. Int J Mol Sci 2020;21:E1778. [PMID: 32150842 DOI: 10.3390/ijms21051778] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
59 Kuley R, Draves KE, Fuller DH, Giltiay NV, Clark EA, Giordano D. B cell activating factor (BAFF) from neutrophils and dendritic cells is required for protective B cell responses against Salmonella typhimurium infection. PLoS One 2021;16:e0259158. [PMID: 34705890 DOI: 10.1371/journal.pone.0259158] [Reference Citation Analysis]
60 de Carvalho JTG, Schneider M, Cuppari L, Grabulosa CC, Cendoroglo M, Dalboni MA. Cholecalciferol Supplementation Did Not Change Interleukin-7 and B cell-Activating Factor Levels and CD95 Expression in B lymphocytes in Patients on Dialysis: A Randomized Pilot-Controlled Trial. J Ren Nutr 2019;29:454-61. [PMID: 30686751 DOI: 10.1053/j.jrn.2018.11.006] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Luo S, Ding S, Liao J, Zhang P, Liu Y, Zhao M, Lu Q. Excessive miR-152-3p Results in Increased BAFF Expression in SLE B-Cells by Inhibiting the KLF5 Expression. Front Immunol 2019;10:1127. [PMID: 31178864 DOI: 10.3389/fimmu.2019.01127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
62 Cassia M, Alberici F, Gallieni M, Jayne D. Lupus nephritis and B-cell targeting therapy. Expert Rev Clin Immunol 2017;13:951-62. [PMID: 28800401 DOI: 10.1080/1744666X.2017.1366855] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
63 Engh JA, Ueland T, Agartz I, Andreou D, Aukrust P, Boye B, Bøen E, Drange OK, Elvsåshagen T, Hope S, Høegh MC, Joa I, Johnsen E, Kroken RA, Lagerberg TV, Lekva T, Malt UF, Melle I, Morken G, Nærland T, Steen VM, Wedervang-Resell K, Weibell MA, Westlye LT, Djurovic S, Steen NE, Andreassen OA. Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study. Schizophr Bull 2021:sbab106. [PMID: 34499169 DOI: 10.1093/schbul/sbab106] [Reference Citation Analysis]
64 Zhang J, Liu X, Xu Y, Li H, Xu Y. Efficacy and safety of belimumab in the treatment of systemic lupus erythematosus: A meta‑analysis. World Acad Sci J 2022;4. [DOI: 10.3892/wasj.2022.143] [Reference Citation Analysis]
65 Liu Y, Li L, Xia Y. BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid. Front Immunol 2017;8:1752. [PMID: 29276517 DOI: 10.3389/fimmu.2017.01752] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 9.6] [Reference Citation Analysis]
66 Holdsworth SR, Gan PY, Kitching AR. Biologics for the treatment of autoimmune renal diseases. Nat Rev Nephrol 2016;12:217-31. [PMID: 26949177 DOI: 10.1038/nrneph.2016.18] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
67 Elsner RA, Shlomchik MJ. Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity. Immunity 2020;53:1136-50. [PMID: 33326765 DOI: 10.1016/j.immuni.2020.11.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
68 Pulendran B. Systems vaccinology: probing humanity's diverse immune systems with vaccines. Proc Natl Acad Sci U S A 2014;111:12300-6. [PMID: 25136102 DOI: 10.1073/pnas.1400476111] [Cited by in Crossref: 112] [Cited by in F6Publishing: 92] [Article Influence: 14.0] [Reference Citation Analysis]
69 Marín-rosales M, Cruz A, Salazar-camarena DC, Santillán-lópez E, Espinoza-garcía N, Muñoz-valle JF, Ramírez-dueñas MG, Oregón-romero E, Orozco-barocio G, Palafox-sánchez CA. High BAFF expression associated with active disease in systemic lupus erythematosus and relationship with rs9514828C>T polymorphism in TNFSF13B gene. Clin Exp Med 2019;19:183-90. [DOI: 10.1007/s10238-019-00549-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
70 Landolt-Marticorena C. The need for preclinical biomarkers in systemic autoimmune rheumatic diseases. J Rheumatol. 2015;42:152-154. [PMID: 25641964 DOI: 10.3899/jrheum.141366] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
71 Jasek M, Bojarska-Junak A, Wagner M, Sobczyński M, Wołowiec D, Roliński J, Karabon L, Kuśnierczyk P. Association of variants in BAFF (rs9514828 and rs1041569) and BAFF-R (rs61756766) genes with the risk of chronic lymphocytic leukemia. Tumour Biol 2016;37:13617-26. [PMID: 27468724 DOI: 10.1007/s13277-016-5182-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
72 Sevdali E, Block Saldana V, Speletas M, Eibel H. BAFF receptor polymorphisms and deficiency in humans. Curr Opin Immunol 2021;71:103-10. [PMID: 34311146 DOI: 10.1016/j.coi.2021.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Imbrechts M, De Samblancx K, Fierens K, Brisse E, Vandenhaute J, Mitera T, Libert C, Smets I, Goris A, Wouters C, Matthys P. IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways. Eur J Immunol 2018;48:1506-21. [DOI: 10.1002/eji.201847578] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
74 Kawakami Y, Saito Y, Nakagawa R, Kurihara Y, Takei K. The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans. Neurosci Lett 2018;683:61-8. [PMID: 29953923 DOI: 10.1016/j.neulet.2018.06.045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
75 Gorosito Serrán M, Fiocca Vernengo F, Beccaria CG, Acosta Rodriguez EV, Montes CL, Gruppi A. The regulatory role of B cells in autoimmunity, infections and cancer: Perspectives beyond IL10 production. FEBS Lett 2015;589:3362-9. [PMID: 26424657 DOI: 10.1016/j.febslet.2015.08.048] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
76 Lokensgard JR, Mutnal MB, Prasad S, Sheng W, Hu S. Glial cell activation, recruitment, and survival of B-lineage cells following MCMV brain infection. J Neuroinflammation 2016;13:114. [PMID: 27207308 DOI: 10.1186/s12974-016-0582-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
77 Yi SG, Gaber AO, Chen W. B-cell response in solid organ transplantation. Front Immunol 2022;13:895157. [DOI: 10.3389/fimmu.2022.895157] [Reference Citation Analysis]
78 Sicard T, Kassardjian A, Julien JP. B cell targeting by molecular adjuvants for enhanced immunogenicity. Expert Rev Vaccines 2020;19:1023-39. [PMID: 33252273 DOI: 10.1080/14760584.2020.1857736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 van de Vosse E, van Ostaijen-Ten Dam MM, Vermaire R, Verhard EM, Waaijer JL, Bakker JA, Bernards ST, Eibel H, van Tol MJ, van Dissel JT, Haverkamp MH. Recurrent respiratory tract infections (RRTI) in the elderly: A late onset mild immunodeficiency? Clin Immunol 2017;180:111-9. [PMID: 28487087 DOI: 10.1016/j.clim.2017.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
80 Gowhari Shabgah A, Shariati-Sarabi Z, Tavakkol-Afshari J, Ghasemi A, Ghoryani M, Mohammadi M. A significant decrease of BAFF, APRIL, and BAFF receptors following mesenchymal stem cell transplantation in patients with refractory rheumatoid arthritis. Gene 2020;732:144336. [PMID: 31935514 DOI: 10.1016/j.gene.2020.144336] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
81 Lahiri A, Varin M, Le Pottier L, Pochard P, Bendaoud B, Youinou P, Pers J. Specific forms of BAFF favor BAFF receptor-mediated epithelial cell survival. Journal of Autoimmunity 2014;51:30-7. [DOI: 10.1016/j.jaut.2014.02.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
82 Mcclure M, Gopaluni S, Jayne D, Jones R. B cell therapy in ANCA-associated vasculitis: current and emerging treatment options. Nat Rev Rheumatol 2018;14:580-91. [DOI: 10.1038/s41584-018-0065-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
83 Mubariki R, Vadasz Z. The role of B cell metabolism in autoimmune diseases. Autoimmun Rev 2022;:103116. [PMID: 35595053 DOI: 10.1016/j.autrev.2022.103116] [Reference Citation Analysis]
84 Ichikawa T, Shimojima Y, Kishida D, Kaneko T, Sekijima Y. Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review. Rheumatol Int 2021;41:1009-17. [PMID: 32253501 DOI: 10.1007/s00296-020-04569-6] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Wang G, Li M, Zheng J, Zhan J, Zheng H, Li R, Wei X. Circulating BAFF as novel biomarker in distinguishing chronic rhinosinusitis with nasal polyps endotypes and predicting postoperative recurrence. Int Immunopharmacol 2022;104:108515. [PMID: 35008009 DOI: 10.1016/j.intimp.2021.108515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Zhao H, Yang J, Qian Q, Wu M, Li M, Xu W. Mesenteric CD103+DCs Initiate Switched Coxsackievirus B3 VP1-Specific IgA Response to Intranasal Chitosan-DNA Vaccine Through Secreting BAFF/IL-6 and Promoting Th17/Tfh Differentiation. Front Immunol 2018;9:2986. [PMID: 30619341 DOI: 10.3389/fimmu.2018.02986] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
87 Guiteras J, Ripoll É, Bolaños N, De Ramon L, Fontova P, Lloberas N, Cruzado JM, Aràn JM, Aviñó A, Eritja R, Gomà M, Taco R, Grinyó JM, Torras J. The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis. Mol Ther Nucleic Acids 2021;24:807-21. [PMID: 33996261 DOI: 10.1016/j.omtn.2021.03.019] [Reference Citation Analysis]
88 Woess C, Tuzlak S, Labi V, Drach M, Bertele D, Schneider P, Villunger A. Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice. Cell Death Differ 2015;22:1477-88. [PMID: 25698446 DOI: 10.1038/cdd.2015.8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
89 Soleto I, Abós B, Castro R, González L, Tafalla C, Granja AG. The BAFF / APRIL axis plays an important role in virus-induced peritoneal responses in rainbow trout. Fish Shellfish Immunol 2017;64:210-7. [PMID: 28302579 DOI: 10.1016/j.fsi.2017.03.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
90 Czaja AJ. Review article: targeting the B cell activation system in autoimmune hepatitis. Aliment Pharmacol Ther 2021;54:902-22. [PMID: 34506662 DOI: 10.1111/apt.16574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
91 Salazar-Camarena DC, Ortíz-Lazareno P, Marín-Rosales M, Cruz A, Muñoz-Valle F, Tapia-Llanos R, Orozco-Barocio G, Machado-Contreras R, Palafox-Sánchez CA. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus. Cytokine 2019;114:115-27. [PMID: 30467093 DOI: 10.1016/j.cyto.2018.11.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
92 Verstappen GM, Kroese FG, Vissink A, Bootsma H. Pharmacotherapy for managing extraglandular symptoms of primary Sjögren’s syndrome. Expert Opinion on Orphan Drugs 2015;3:125-39. [DOI: 10.1517/21678707.2015.1010510] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
93 Allman WR, Dey R, Liu L, Siddiqui S, Coleman AS, Bhattacharya P, Yano M, Uslu K, Takeda K, Nakhasi HL, Akkoyunlu M. TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection. Proc Natl Acad Sci U S A 2015;112:E4094-103. [PMID: 26170307 DOI: 10.1073/pnas.1421580112] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
94 Hu H, Yang H, Liu Y, Yan B. Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System. Front Med 2022;8:833114. [DOI: 10.3389/fmed.2021.833114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
95 Bojadzic D, Buchwald P. Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions. Curr Top Med Chem 2018;18:674-99. [PMID: 29848279 DOI: 10.2174/1568026618666180531092503] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
96 Merino-Vico A, van Hamburg JP, Tas SW. B Lineage Cells in ANCA-Associated Vasculitis. Int J Mol Sci 2021;23:387. [PMID: 35008813 DOI: 10.3390/ijms23010387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
97 Chen BM, Cheng TL, Roffler SR. Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies. ACS Nano 2021;15:14022-48. [PMID: 34469112 DOI: 10.1021/acsnano.1c05922] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
98 Allegra A, Musolino C, Tonacci A, Pioggia G, Casciaro M, Gangemi S. Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role. Cancers (Basel) 2020;12:E524. [PMID: 32102441 DOI: 10.3390/cancers12020524] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
99 Ritter C, Förster D, Albrecht P, Hartung HP, Kieseier BC, Lehmann HC. IVIG regulates BAFF expression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J Neuroimmunol 2014;274:225-9. [PMID: 25002077 DOI: 10.1016/j.jneuroim.2014.06.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
100 Carrillo-Ballesteros FJ, Palafox-Sánchez CA, Franco-Topete RA, Muñoz-Valle JF, Orozco-Barocio G, Martínez-Bonilla GE, Gómez-López CE, Marín-Rosales M, López-Villalobos EF, Luquin S, Castañeda-Chávez A, Oregon-Romero E. Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures. Clin Exp Med 2020;20:615-26. [PMID: 32506205 DOI: 10.1007/s10238-020-00637-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
101 Cipolla GA, Park JK, de Oliveira LA, Lobo-Alves SC, de Almeida RC, Farias TD, Lemos Dde S, Malheiros D, Lavker RM, Petzl-Erler ML. A 3'UTR polymorphism marks differential KLRG1 mRNA levels through disruption of a miR-584-5p binding site and associates with pemphigus foliaceus susceptibility. Biochim Biophys Acta 2016;1859:1306-13. [PMID: 27424220 DOI: 10.1016/j.bbagrm.2016.07.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
102 Alturaiki W, Mcfarlane AJ, Rose K, Corkhill R, Mcnamara PS, Schwarze J, Flanagan BF. Expression of the B cell differentiation factor BAFF and chemokine CXCL13 in a murine model of Respiratory Syncytial Virus infection. Cytokine 2018;110:267-71. [DOI: 10.1016/j.cyto.2018.01.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
103 Laurent SA, Hoffmann FS, Kuhn PH, Cheng Q, Chu Y, Schmidt-Supprian M, Hauck SM, Schuh E, Krumbholz M, Rübsamen H, Wanngren J, Khademi M, Olsson T, Alexander T, Hiepe F, Pfister HW, Weber F, Jenne D, Wekerle H, Hohlfeld R, Lichtenthaler SF, Meinl E. γ-Secretase directly sheds the survival receptor BCMA from plasma cells. Nat Commun 2015;6:7333. [PMID: 26065893 DOI: 10.1038/ncomms8333] [Cited by in Crossref: 135] [Cited by in F6Publishing: 131] [Article Influence: 19.3] [Reference Citation Analysis]
104 Yang M, Yi P, Jiang J, Zhao M, Wu H, Lu Q. Dysregulated translational factors and epigenetic regulations orchestrate in B cells contributing to autoimmune diseases. Int Rev Immunol 2021;:1-25. [PMID: 34445929 DOI: 10.1080/08830185.2021.1964498] [Reference Citation Analysis]
105 Kim H, Won BH, Choi JI, Lee I, Lee JH, Park JH, Choi YS, Kim JH, Cho S, Lim JB, Lee BS. BRAK and APRIL as novel biomarkers for ovarian tumors. Biomark Med 2022. [PMID: 35588310 DOI: 10.2217/bmm-2021-1014] [Reference Citation Analysis]
106 Hall S, Agrawal DK. Key mediators in the immunopathogenesis of allergic asthma. Int Immunopharmacol 2014;23:316-29. [PMID: 24933589 DOI: 10.1016/j.intimp.2014.05.034] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
107 Delaleu N, Mydel P, Kwee I, Brun JG, Jonsson MV, Jonsson R. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren’s syndrome. Arthritis Rheumatol. 2015;67:1084-1095. [PMID: 25545990 DOI: 10.1002/art.39015] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 9.1] [Reference Citation Analysis]
108 Bloom DD, Reshetylo S, Nytes C, Goodsett CT, Hematti P. Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity. J Immunother 2018;41:213-23. [PMID: 29309290 DOI: 10.1097/CJI.0000000000000209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
109 Kimura A, Yoshikura N, Koumura A, Hayashi Y, Inuzuka T. B-cell-activating factor belonging to the tumor necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) levels in cerebrospinal fluid of patients with meningoencephalitis. Journal of the Neurological Sciences 2015;352:79-83. [DOI: 10.1016/j.jns.2015.03.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
110 Fazio G, Turazzi N, Cazzaniga V, Kreuzaler M, Maglia O, Magnani CF, Biagi E, Rolink A, Biondi A, Cazzaniga G. TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia. Br J Haematol 2018;182:434-6. [PMID: 28573703 DOI: 10.1111/bjh.14794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
111 Braun T, Juenemann M, Dornes K, El-Shazly J, Schramm P, Bick-Ackerschott S, Kaps M, Gerriets T, Blaes F, Tschernatsch M. BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases. Int J Neurosci 2020;:1-6. [PMID: 32602764 DOI: 10.1080/00207454.2020.1784167] [Reference Citation Analysis]
112 Meng H, Li H, Ohe R, Naing YA, Yang S, Kabasawa T, Kato T, Osakabe M, Ohtake H, Ishida A, Lu J, Zhang L, Ohta N, Kakehata S, Joh K, Shi Q, Jin X, Geng J, Yamakawa M. Thymic stromal lymphopoietin in tonsillar follicular dendritic cells correlates with elevated serum immunoglobulin A titer by promoting tonsillar immunoglobulin A class switching in immunoglobulin A nephropathy. Transl Res 2016;176:1-17. [PMID: 27187742 DOI: 10.1016/j.trsl.2016.04.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
113 Leyva-Castillo JM, Jabara HH, Wenzel J, McGurk A, Wong D, Bieber T, Geha RS. APRIL expression is upregulated in atopic dermatitis skin lesions and at sites of antigen driven allergic skin inflammation in mice. Clin Immunol 2020;219:108556. [PMID: 32777271 DOI: 10.1016/j.clim.2020.108556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Bolkun L, Lemancewicz D, Jablonska E, Szumowska A, Bolkun-Skornicka U, Moniuszko M, Dzieciol J, Kloczko J. Prognostic significance of ligands belonging to tumour necrosis factor superfamily in acute lymphoblastic leukaemia. Leuk Res 2015;39:290-5. [PMID: 25582383 DOI: 10.1016/j.leukres.2014.12.012] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
115 Li P, Cheng D, Wen J, Ni X, Li X, Xie K, Chen J. The immunophenotyping of different stages of BK virus allograft nephropathy. Ren Fail 2019;41:855-61. [PMID: 31535918 DOI: 10.1080/0886022X.2019.1617168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
116 Benitez A, Torralba K, Ngo M, Salto LM, Choi KS, De Vera ME, Payne KJ. Belimumab alters transitional B-cell subset proportions in patients with stable systemic lupus erythematosus. Lupus 2019;28:1337-43. [PMID: 31423896 DOI: 10.1177/0961203319869468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
117 Sturm N, Quinterot M, Guyot JP, Righini C, Daamen WF, van Kuppevelt TH, Huard B. Polarized Secretion of APRIL by the Tonsil Epithelium Upon Toll-Like Receptor Stimulation. Front Immunol 2021;12:715724. [PMID: 34484218 DOI: 10.3389/fimmu.2021.715724] [Reference Citation Analysis]
118 Lendak DF, Mihajlović DM, Novakov-Mikić AS, Mitić IM, Boban JM, Brkić SV. The role of TNF-α superfamily members in immunopathogenesis of sepsis. Cytokine 2018;111:125-30. [PMID: 30142533 DOI: 10.1016/j.cyto.2018.08.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
119 Brummer T, Ruck T, Meuth SG, Zipp F, Bittner S. Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders. Ther Adv Neurol Disord 2021;14:17562864211035542. [PMID: 34457039 DOI: 10.1177/17562864211035542] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 den Hartog G, van Osch TLJ, Vos M, Meijer B, Savelkoul HFJ, van Neerven RJJ, Brugman S. BAFF augments IgA2 and IL-10 production by TLR7/8 stimulated total peripheral blood B cells. Eur J Immunol 2018;48:283-92. [PMID: 28921509 DOI: 10.1002/eji.201646861] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
121 Ikeda J, Shimojima Y, Yoshinaga T, Kodaira M, Nishina S, Ito K, Sekijima Y. Alteration of BAFF and APRIL in the cerebrospinal fluid based on the therapeutic response in primary central nervous system B-cell lymphoma. J Clin Neurosci 2020;81:72-5. [PMID: 33222973 DOI: 10.1016/j.jocn.2020.09.005] [Reference Citation Analysis]
122 Thames AD, Briones MS, Magpantay LI, Martinez-Maza O, Singer EJ, Hinkin CH, Morgello S, Gelman BB, Moore DJ, Heizerling K, Levine AJ. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS 2015;29:1483-91. [PMID: 26244388 DOI: 10.1097/QAD.0000000000000706] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
123 Liu C, Zhang P, Zhang W. Immunological mechanism of IgG4-related disease. J Transl Autoimmun 2020;3:100047. [PMID: 32743528 DOI: 10.1016/j.jtauto.2020.100047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
124 Lendak DF, Mihajlović DM, Novakov-Mikić AS, Boban JM, Ubavić M, Brkić SV. APRIL and sTACI could be predictors of multiorgan dysfunction syndrome in sepsis. Virulence 2018;9:946-53. [PMID: 29781374 DOI: 10.1080/21505594.2018.1462636] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
125 Kim H, Choi YS, Kim JS, Kim S, Won BH, Won YB, Lee I, Lee JH, Yun BH, Seo SK, Park JH, Cho S, Shin JH, Lim JB, Lee BS. Identification of Serum Biomarkers for Diagnosis of Endometriosis Using Multiplex Immunoassays. Reprod Sci 2020;27:1139-47. [PMID: 32046464 DOI: 10.1007/s43032-019-00124-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Lee WS, Amengual O. B cells targeting therapy in the management of systemic lupus erythematosus. Immunol Med 2020;43:16-35. [PMID: 32107989 DOI: 10.1080/25785826.2019.1698929] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
127 Kawakami T, Mizushima I, Yamada K, Fujii H, Ito K, Yasuno T, Izui S, Yamagishi M, Huard B, Kawano M. Abundant a proliferation-inducing ligand (APRIL)-producing macrophages contribute to plasma cell accumulation in immunoglobulin G4-related disease. Nephrol Dial Transplant 2019;34:960-9. [PMID: 30325430 DOI: 10.1093/ndt/gfy296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
128 Xu H, Dong P, He X, Ma X, Xue D, Zhang Y, Zhang X. B-cell-activating factor code and human cytomegalovirus infection in renal transplant recipients: BAFF code and HCMV-TLR. Microbiol Immunol 2014;58:439-48. [DOI: 10.1111/1348-0421.12167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
129 Deng B, Liu X, Li X, Zhang X, Quan C, Chen X. Raised cerebrospinal fluid BAFF and APRIL levels in anti- N -methyl- d -aspartate receptor encephalitis: Correlation with clinical outcome. Journal of Neuroimmunology 2017;305:84-91. [DOI: 10.1016/j.jneuroim.2017.01.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
130 Gardam S, Brink R. Non-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures. Front Immunol 2014;4:509. [PMID: 24432023 DOI: 10.3389/fimmu.2013.00509] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
131 Chasset F, de Masson A, Le Buanec H, Xhaard A, de Fontbrune FS, Robin M, Rybojad M, Parquet N, Brignier AC, Coman T, Bengoufa D, Bergeron A, Peffault de Latour R, Bagot M, Bensussan A, Socié G, Bouaziz JD. APRIL levels are associated with disease activity in human chronic graft-versus-host disease. Haematologica 2016;101:e312-5. [PMID: 26992945 DOI: 10.3324/haematol.2016.145409] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
132 Salazar-camarena DC, Ortiz-lazareno PC, Cruz A, Oregon-romero E, Machado-contreras JR, Muñoz-valle JF, Orozco-lópez M, Marín-rosales M, Palafox-sánchez CA. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus. Lupus 2016;25:582-92. [DOI: 10.1177/0961203315608254] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 8.4] [Reference Citation Analysis]
133 Tafalla C, Granja AG. Novel Insights on the Regulation of B Cell Functionality by Members of the Tumor Necrosis Factor Superfamily in Jawed Fish. Front Immunol 2018;9:1285. [PMID: 29930556 DOI: 10.3389/fimmu.2018.01285] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
134 Maglione PJ, Simchoni N, Cunningham-Rundles C. Toll-like receptor signaling in primary immune deficiencies. Ann N Y Acad Sci 2015;1356:1-21. [PMID: 25930993 DOI: 10.1111/nyas.12763] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
135 Dostert C, Grusdat M, Letellier E, Brenner D. The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond. Physiological Reviews 2019;99:115-60. [DOI: 10.1152/physrev.00045.2017] [Cited by in Crossref: 76] [Cited by in F6Publishing: 86] [Article Influence: 25.3] [Reference Citation Analysis]
136 Giordano D, Draves KE, Li C, Hohl TM, Clark EA. Nitric oxide regulates BAFF expression and T cell-independent antibody responses. J Immunol. 2014;193:1110-1120. [PMID: 24951820 DOI: 10.4049/jimmunol.1303158] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
137 Chong AS, Sciammas R. Memory B cells in transplantation. Transplantation 2015;99:21-8. [PMID: 25525921 DOI: 10.1097/TP.0000000000000545] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
138 Hirose M, Arai T, Sugimoto C, Takimoto T, Sugawara R, Minomo S, Shintani S, Takeuchi N, Katayama K, Inoue Y, Kagawa T, Kasai T, Akira M, Inoue Y. B cell-activating factors in autoimmune pulmonary alveolar proteinosis. Orphanet J Rare Dis 2021;16:115. [PMID: 33653382 DOI: 10.1186/s13023-021-01755-y] [Reference Citation Analysis]
139 Sciascia S, Radin M, Roccatello D, Sanna G, Bertolaccini ML. Recent advances in the management of systemic lupus erythematosus. F1000Res 2018;7:F1000 Faculty Rev-970. [PMID: 30026918 DOI: 10.12688/f1000research.13941.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
140 Pavletič M, Korva M, Knap N, Bogovič P, Lusa L, Strle K, Nahtigal Klevišar M, Vovko T, Tomažič J, Lotrič-Furlan S, Strle F, Avšič-Županc T. Upregulated Intrathecal Expression of VEGF-A and Long Lasting Global Upregulation of Proinflammatory Immune Mediators in Vaccine Breakthrough Tick-Borne Encephalitis. Front Cell Infect Microbiol 2021;11:696337. [PMID: 34277474 DOI: 10.3389/fcimb.2021.696337] [Reference Citation Analysis]
141 Lang J, Zhang B, Kelly M, Peterson JN, Barbee J, Freed BM, Di Santo JP, Matsuda JL, Torres RM, Pelanda R. Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice. Blood Adv 2017;1:2729-41. [PMID: 29296925 DOI: 10.1182/bloodadvances.2017010090] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
142 Alvarez-Rodriguez L, Riancho-Zarrabeitia L, Calvo-Alén J, López-Hoyos M, Martínez-Taboada V. Peripheral B-Cell Subset Distribution in Primary Antiphospholipid Syndrome. Int J Mol Sci 2018;19:E589. [PMID: 29462939 DOI: 10.3390/ijms19020589] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
143 Mohamed Ezzat MH, Mohammed AA, Ismail RIH, Shaheen KYA. High serum APRIL levels strongly correlate with disease severity in pediatric atopic eczema. Int J Dermatol 2016;55:e494-500. [DOI: 10.1111/ijd.13230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
144 Wardowska A, Komorniczak M, Skoniecka A, Bułło-Piontecka B, Lisowska KA, Dębska-Ślizień MA, Pikuła M. Alterations in peripheral blood B cells in systemic lupus erythematosus patients with renal insufficiency. Int Immunopharmacol 2020;83:106451. [PMID: 32248020 DOI: 10.1016/j.intimp.2020.106451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
145 Yamada K, Huang ZQ, Raska M, Reily C, Anderson JC, Suzuki H, Kiryluk K, Gharavi AG, Julian BA, Willey CD, Novak J. Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy. Kidney Dis (Basel) 2020;6:168-80. [PMID: 32523959 DOI: 10.1159/000505748] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
146 Matsuda Y, Haneda M, Kadomatsu K, Kobayashi T. A proliferation-inducing ligand sustains the proliferation of human naïve (CD27−) B cells and mediates their differentiation into long-lived plasma cells in vitro via transmembrane activator and calcium modulator and cyclophilin ligand interactor and B-cell mature antigen. Cellular Immunology 2015;295:127-36. [DOI: 10.1016/j.cellimm.2015.02.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
147 Cuesta-Mateos C, Alcaraz-Serna A, Somovilla-Crespo B, Muñoz-Calleja C. Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets. Front Immunol 2017;8:1936. [PMID: 29387053 DOI: 10.3389/fimmu.2017.01936] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
148 Tang F, Chen X, Mao Y, Wan S, Ai S, Yang H, Liu G, Zou Y, Lin M, Dan L. Orbital fibroblasts of Graves' orbitopathy stimulated with proinflammatory cytokines promote B cell survival by secreting BAFF. Mol Cell Endocrinol 2017;446:1-11. [PMID: 28087387 DOI: 10.1016/j.mce.2017.01.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
149 Wang B, Chen S, Li Y, Xuan J, Liu Y, Shi G. Targeted Therapy for Primary Sjögren's Syndrome: Where are We Now? BioDrugs 2021;35:593-610. [PMID: 34731460 DOI: 10.1007/s40259-021-00505-7] [Reference Citation Analysis]
150 Ikeda J, Shimojima Y, Usami Y, Ueno KI, Kishida D, Sekijima Y. Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis. Clin Rheumatol 2020;39:1803-11. [PMID: 32036585 DOI: 10.1007/s10067-020-04971-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Miyazaki Y, Niino M, Takahashi E, Suzuki M, Mizuno M, Hisahara S, Fukazawa T, Amino I, Nakano F, Nakamura M, Akimoto S, Minami N, Fujiki N, Doi S, Shimohama S, Terayama Y, Kikuchi S. Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis. Clinical Immunology 2018;187:95-101. [DOI: 10.1016/j.clim.2017.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
152 Rose WA 2nd, Okragly AJ, Hu NN, Daniels MR, Martin AP, Koh YT, Kikly K, Benschop RJ. Interleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production. Front Immunol 2018;9:2871. [PMID: 30574145 DOI: 10.3389/fimmu.2018.02871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
153 Lee YH, Song GG. Comparative efficacy and safety of intravenous or subcutaneous belimumab in combination with standard therapy in patients with active systemic lupus erythematosus: a Bayesian network meta-analysis of randomized controlled trials. Lupus 2018;27:112-9. [PMID: 28592201 DOI: 10.1177/0961203317713143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
154 Capuano M, Sommese L, Pignalosa O, Parente D, Fabbricini R, Nicoletti GF, De Pascale MR, Schiano C, Napoli C. Current Clinical Applications of Extracorporeal Photochemotherapy: Extracorporeal Photochemotherapy. Ther Apher Dial 2015;19:103-10. [DOI: 10.1111/1744-9987.12245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
155 Zhang Y, Tian J, Xiao F, Zheng L, Zhu X, Wu L, Zhao C, Wang S, Rui K, Zou H, Lu L. B cell-activating factor and its targeted therapy in autoimmune diseases. Cytokine & Growth Factor Reviews 2021. [DOI: 10.1016/j.cytogfr.2021.11.004] [Reference Citation Analysis]
156 Petzl-Erler ML. Beyond the HLA polymorphism: A complex pattern of genetic susceptibility to pemphigus. Genet Mol Biol 2020;43:e20190369. [PMID: 32639508 DOI: 10.1590/1678-4685-gmb-2019-0369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
157 Maglione PJ, Ko HM, Tokuyama M, Gyimesi G, Soof C, Li M, Sanchez E, Chen H, Radigan L, Berenson J, Cunningham-Rundles C. Serum B-Cell Maturation Antigen (BCMA) Levels Differentiate Primary Antibody Deficiencies. J Allergy Clin Immunol Pract 2020;8:283-291.e1. [PMID: 31430592 DOI: 10.1016/j.jaip.2019.08.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
158 Shurin MR, Ma Y, Keskinov AA, Zhao R, Lokshin A, Agassandian M, Shurin GV. BAFF and APRIL from Activin A-Treated Dendritic Cells Upregulate the Antitumor Efficacy of Dendritic Cells In Vivo. Cancer Res 2016;76:4959-69. [PMID: 27364554 DOI: 10.1158/0008-5472.CAN-15-2668] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
159 Coquery CM, Loo WM, Wade NS, Bederman AG, Tung KS, Lewis JE, Hess H, Erickson LD. BAFF regulates follicular helper t cells and affects their accumulation and interferon-γ production in autoimmunity. Arthritis Rheumatol 2015;67:773-84. [PMID: 25385309 DOI: 10.1002/art.38950] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
160 Seys LJ, Verhamme FM, Schinwald A, Hammad H, Cunoosamy DM, Bantsimba-Malanda C, Sabirsh A, McCall E, Flavell L, Herbst R, Provoost S, Lambrecht BN, Joos GF, Brusselle GG, Bracke KR. Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2015;192:706-18. [PMID: 26266827 DOI: 10.1164/rccm.201501-0103OC] [Cited by in Crossref: 65] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
161 Jasek M, Bojarska-Junak A, Sobczyński M, Wagner M, Chocholska S, Roliński J, Wołowiec D, Karabon L. Association of Common Variants of TNFSF13 and TNFRSF13B Genes with CLL Risk and Clinical Picture, as Well as Expression of Their Products-APRIL and TACI Molecules. Cancers (Basel) 2020;12:E2873. [PMID: 33036273 DOI: 10.3390/cancers12102873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
162 Sevdali E, Katsantoni E, Smulski CR, Moschovi M, Palassopoulou M, Kolokotsa EN, Argentou N, Giannakoulas N, Adamaki M, Vassilopoulos G, Polychronopoulou S, Germenis AE, Eibel H, Speletas M. BAFF/APRIL System Is Functional in B-Cell Acute Lymphoblastic Leukemia in a Disease Subtype Manner. Front Oncol 2019;9:594. [PMID: 31380267 DOI: 10.3389/fonc.2019.00594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
163 Wong D, Li L, Jurado S, King A, Bamford R, Wall M, Walia M, Kelly G, Walkley C, Tarlinton D, Strasser A, Heierhorst J. The Transcription Factor ASCIZ and Its Target DYNLL1 Are Essential for the Development and Expansion of MYC-Driven B Cell Lymphoma. Cell Reports 2016;14:1488-99. [DOI: 10.1016/j.celrep.2016.01.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
164 Song Y, Buchwald P. TNF superfamily protein-protein interactions: feasibility of small- molecule modulation. Curr Drug Targets 2015;16:393-408. [PMID: 25706111 DOI: 10.2174/1389450116666150223115628] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
165 Alaibac M. Biological therapy of autoimmune blistering diseases. Expert Opin Biol Ther 2019;19:149-56. [PMID: 30558452 DOI: 10.1080/14712598.2019.1559291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
166 Bajda S, Blazquez-Navarro A, Samans B, Wehler P, Kaliszczyk S, Amini L, Schmueck-Henneresse M, Witzke O, Dittmer U, Westhoff TH, Viebahn R, Reinke P, Thomusch O, Hugo C, Olek S, Roch T, Babel N. The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation. Sci Rep 2020;10:19594. [PMID: 33177622 DOI: 10.1038/s41598-020-76607-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
167 Friebus-Kardash J, Wilde B, Keles D, Heinold A, Kribben A, Witzke O, Heinemann FM, Eisenberger U. Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival. Transpl Immunol 2018;47:10-7. [PMID: 29277566 DOI: 10.1016/j.trim.2017.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
168 Xu P, Shao X, Ou Y, Zhan Y, Ji L, Zhuang X, Li Y, Ma Y, Wu D, Qiao T, Wang X, Chen H, Cheng Y. Neutrophils contribute to elevated BAFF levels to modulate adaptive immunity in patients with primary immune thrombocytopenia by CD62P and PSGL1 interaction. Clin & Trans Imm 2022;11. [DOI: 10.1002/cti2.1399] [Reference Citation Analysis]
169 Namazi S, Tajik N, Ziaee V, Sadr M, Soltani S, Rezaei A, Zoghi S, Rezaei N. APRIL gene polymorphism and serum sAPRIL levels in children with systemic lupus erythematosus. Clin Rheumatol 2017;36:831-6. [PMID: 27878683 DOI: 10.1007/s10067-016-3466-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
170 Kaczor-urbanowicz KE, Wong DT. Proteomics. Translational Systems Medicine and Oral Disease. Elsevier; 2020. pp. 93-118. [DOI: 10.1016/b978-0-12-813762-8.00004-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
171 Lee Y, Kim YJ, Jung YJ, Kim KH, Kwon YM, Kim SI, Kang SM. Systems biology from virus to humans. J Anal Sci Technol 2015;6:3. [PMID: 26269748 DOI: 10.1186/s40543-015-0047-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
172 Zeng Q, Zhou Z, Qin S, Yao Y, Qin J, Zhang H, Zhang R, Xu C, Zhang S, Huang S, Chen L. Rapamycin inhibits B-cell activating factor (BAFF)-stimulated cell proliferation and survival by suppressing Ca2+-CaMKII-dependent PTEN/Akt-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells. Cell Calcium 2020;87:102171. [PMID: 32062191 DOI: 10.1016/j.ceca.2020.102171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
173 Sanchez-nino MD, Ortiz A. 'That Obscure Object of Desire': in systemic lupus erythematosus B-cell activating factor/B-lymphocyte stimulator is targeted both by the immune system and by physicians. Nephrology Dialysis Transplantation 2015;30:394-400. [DOI: 10.1093/ndt/gfu213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
174 Pena Dias J, Haberlen SA, Dobs AS, Lake JE, Palella FJ, Kingsley LA, Price JC, Basaria S, Varadhan R, Margolick JB, Thio CL, Brown TT. Longitudinal Changes in Sex Hormone-Binding Globulin in Men With HIV. J Acquir Immune Defic Syndr 2021;87:1178-86. [PMID: 33990494 DOI: 10.1097/QAI.0000000000002723] [Reference Citation Analysis]
175 Singh N, Kumar B, Aluri V, Lenert P. Interfering with baffled B cells at the lupus tollway: Promises, successes, and failed expectations. J Allergy Clin Immunol 2016;137:1325-33. [PMID: 26953155 DOI: 10.1016/j.jaci.2015.12.1326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
176 Saulep-Easton D, Vincent FB, Quah PS, Wei A, Ting SB, Croce CM, Tam C, Mackay F. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia 2016;30:163-72. [PMID: 26139429 DOI: 10.1038/leu.2015.174] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
177 Im J, Baik JE, Lee D, Park OJ, Park DH, Yun CH, Han SH. Bacterial Lipoproteins Induce BAFF Production via TLR2/MyD88/JNK Signaling Pathways in Dendritic Cells. Front Immunol 2020;11:564699. [PMID: 33123136 DOI: 10.3389/fimmu.2020.564699] [Reference Citation Analysis]
178 Prieto-Peña D, Genre F, Remuzgo-Martínez S, Pulito-Cueto V, Atienza-Mateo B, Llorca J, Sevilla-Pérez B, Ortego-Centeno N, Lera-Gómez L, Leonardo MT, Peñalba A, Narváez J, Martín-Penagos L, Rodrigo E, Miranda-Filloy JA, Caminal-Montero L, Collado P, Pérez JS, de Argila D, Rubio E, Luque ML, Blanco-Madrigal JM, Galíndez-Agirregoikoa E, Gualillo O, Martín J, Castañeda S, Blanco R, González-Gay MA, López-Mejías R. BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis. Sci Rep 2021;11:11510. [PMID: 34075170 DOI: 10.1038/s41598-021-91055-z] [Reference Citation Analysis]
179 Heukels P, Moor C, von der Thüsen J, Wijsenbeek M, Kool M. Inflammation and immunity in IPF pathogenesis and treatment. Respiratory Medicine 2019;147:79-91. [DOI: 10.1016/j.rmed.2018.12.015] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 22.7] [Reference Citation Analysis]
180 Wang A, Rojas O, Lee D, Gommerman JL. Regulation of neuroinflammation by B cells and plasma cells. Immunol Rev 2021;299:45-60. [PMID: 33107072 DOI: 10.1111/imr.12929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
181 Blinkenberg M, Soelberg Sørensen P. Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage Agents. CNS Drugs 2017;31:357-71. [PMID: 28285378 DOI: 10.1007/s40263-017-0414-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
182 So BYF, Yap DYH, Chan TM. B Cells in Primary Membranous Nephropathy: Escape from Immune Tolerance and Implications for Patient Management. Int J Mol Sci 2021;22:13560. [PMID: 34948358 DOI: 10.3390/ijms222413560] [Reference Citation Analysis]
183 Jourdan M, Cren M, Robert N, Bolloré K, Fest T, Duperray C, Guilloton F, Hose D, Tarte K, Klein B. IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors. Leukemia 2014;28:1647-56. [DOI: 10.1038/leu.2014.61] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 9.1] [Reference Citation Analysis]
184 Lieury A, Chanal M, Androdias G, Reynolds R, Cavagna S, Giraudon P, Confavreux C, Nataf S. Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions: Glia Remodeling in MS Spinal Cord. Glia 2014;62:1645-58. [DOI: 10.1002/glia.22705] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
185 Wang X, Huang J, Zhang A, Fang C, Ma Q, Jiang P. Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves' disease. BMC Endocr Disord 2021;21:88. [PMID: 33926416 DOI: 10.1186/s12902-021-00752-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Ahmed AR, Shetty S, Kaveri S, Spigelman ZS. Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up. Journal of the American Academy of Dermatology 2016;74:700-708.e3. [DOI: 10.1016/j.jaad.2015.11.030] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
187 Figgett WA, Deliyanti D, Fairfax KA, Quah PS, Wilkinson-berka JL, Mackay F. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers. Journal of Autoimmunity 2015;61:9-16. [DOI: 10.1016/j.jaut.2015.04.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
188 Kim MS, Kim TS. Aminoacyl tRNA Synthetase-Interacting Multifunctional Protein 1 Acts as a Novel B Cell-Activating Factor In Vitro and In Vivo. J Immunol 2015;194:4729-36. [PMID: 25870240 DOI: 10.4049/jimmunol.1401352] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
189 Squatrito D, Emmi G, Silvestri E, Ciucciarelli L, D'Elios MM, Prisco D, Emmi L. Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside. Auto Immun Highlights 2014;5:33-45. [PMID: 26000154 DOI: 10.1007/s13317-014-0058-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
190 Tas SW, Baeten DL. Recent Advances in the Treatment of Immune-Mediated Inflammatory Diseases. Methods Mol Biol 2016;1371:143-55. [PMID: 26530799 DOI: 10.1007/978-1-4939-3139-2_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
191 Eriksson K, Fei G, Lundmark A, Benchimol D, Lee L, Hu YOO, Kats A, Saevarsdottir S, Catrina AI, Klinge B, Andersson AF, Klareskog L, Lundberg K, Jansson L, Yucel-Lindberg T. Periodontal Health and Oral Microbiota in Patients with Rheumatoid Arthritis. J Clin Med 2019;8:E630. [PMID: 31072030 DOI: 10.3390/jcm8050630] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
192 Cogollo E, Silva MA, Isenberg D. Profile of atacicept and its potential in the treatment of systemic lupus erythematosus. Drug Des Devel Ther 2015;9:1331-9. [PMID: 25834391 DOI: 10.2147/DDDT.S71276] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
193 Shetty S, Ahmed AR. Rituximab in the treatment of pemphigus. Expert Opinion on Orphan Drugs 2016;5:99-109. [DOI: 10.1080/21678707.2017.1269647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
194 Bakhuraysah MM, Theotokis P, Lee JY, Alrehaili AA, Aui PM, Figgett WA, Azari MF, Abou-Afech JP, Mackay F, Siatskas C, Alderuccio F, Strittmatter SM, Grigoriadis N, Petratos S. B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF. Sci Rep 2021;11:2890. [PMID: 33536561 DOI: 10.1038/s41598-021-82346-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
195 Hong S, Park KH, Lee YE, Shin S, Kim HJ, Kim YM. Antibody microarray analysis of the amniotic fluid proteome for predicting the outcome of rescue cerclage in patients with cervical insufficiency. Biosci Rep 2021;41:BSR20210174. [PMID: 34195783 DOI: 10.1042/BSR20210174] [Reference Citation Analysis]
196 Schuster AM, Miesgang N, Steines L, Bach C, Banas B, Bergler T. B-cell activating factor BAFF as a novel alert marker for the immunological risk stratification after kidney transplantation. Immunol Res 2021. [PMID: 34373996 DOI: 10.1007/s12026-021-09205-4] [Reference Citation Analysis]
197 Lin Y, Yao X, Yan M, Zhou L, Huang W, Xiao Y, Wu D, Chen J. Integrated analysis of transcriptomics to identify hub genes in primary Sjögren's syndrome. Oral Dis 2021. [PMID: 34145926 DOI: 10.1111/odi.13943] [Reference Citation Analysis]
198 Doerfler PA, Nayak S, Corti M, Morel L, Herzog RW, Byrne BJ. Targeted approaches to induce immune tolerance for Pompe disease therapy. Mol Ther Methods Clin Dev 2016;3:15053. [PMID: 26858964 DOI: 10.1038/mtm.2015.53] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
199 Narayanan P, Curtis BR, Shen L, Schneider E, Tami JA, Paz S, Burel SA, Tai LJ, Machemer T, Kwoh TJ, Xia S, Shattil SJ, Witztum JL, Engelhardt JA, Henry SP, Monia BP, Hughes SG. Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia. Nucleic Acid Ther 2020;30:94-103. [PMID: 32043907 DOI: 10.1089/nat.2019.0829] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
200 Kwun J, Manook M, Page E, Burghuber C, Hong J, Knechtle SJ. Crosstalk Between T and B Cells in the Germinal Center After Transplantation. Transplantation 2017;101:704-12. [PMID: 27906827 DOI: 10.1097/TP.0000000000001588] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 6.8] [Reference Citation Analysis]
201 Figgett WA, Vincent FB, Saulep-Easton D, Mackay F. Roles of ligands from the TNF superfamily in B cell development, function, and regulation. Semin Immunol 2014;26:191-202. [PMID: 24996229 DOI: 10.1016/j.smim.2014.06.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
202 Peck AB, Nguyen CQ, Ambrus J. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease. Int J Mol Sci 2021;22:1919. [PMID: 33671965 DOI: 10.3390/ijms22041919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
203 Frigyesi I, Adolfsson J, Ali M, Kronborg Christophersen M, Johnsson E, Turesson I, Gullberg U, Hansson M, Nilsson B. Robust isolation of malignant plasma cells in multiple myeloma. Blood 2014;123:1336-40. [DOI: 10.1182/blood-2013-09-529800] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
204 Khorooshi R, Asgari N, Mørch MT, Berg CT, Owens T. Hypersensitivity Responses in the Central Nervous System. Front Immunol 2015;6:517. [PMID: 26500654 DOI: 10.3389/fimmu.2015.00517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
205 Doerfler PA, Nayak S, Herzog RW, Morel L, Byrne BJ. BAFF blockade prevents anti-drug antibody formation in a mouse model of Pompe disease. Clin Immunol 2015;158:140-7. [PMID: 25842186 DOI: 10.1016/j.clim.2015.03.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
206 Komocsar WJ, Blackbourne JL, Halstead CA, Winstead CJ, Wierda D. Fully human anti-BAFF inhibitory monoclonal antibody tabalumab does not adversely affect T-dependent antibody responses in cynomolgus monkey (Macaca fasicularis): A summary of three pre-clinical immunotoxicology evaluations. J Immunotoxicol 2016;13:7-19. [PMID: 25585959 DOI: 10.3109/1547691X.2014.994793] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
207 Terzulli M, Contreras-Ruiz L, Kugadas A, Masli S, Gadjeva M. TSP-1 Deficiency Alters Ocular Microbiota: Implications for Sjögren's Syndrome Pathogenesis. J Ocul Pharmacol Ther 2015;31:413-8. [PMID: 26352162 DOI: 10.1089/jop.2015.0017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
208 López P, Rodríguez-Carrio J, Caminal-Montero L, Mozo L, Suárez A. A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients. Sci Rep 2016;6:20651. [PMID: 26847824 DOI: 10.1038/srep20651] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
209 Lunde S, Kristoffersen EK, Sapkota D, Risa K, Dahl O, Bruland O, Mella O, Fluge Ø. Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome. PLoS One 2016;11:e0161226. [PMID: 27536947 DOI: 10.1371/journal.pone.0161226] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
210 Nakayama Y, Kosek J, Capone L, Hur EM, Schafer PH, Ringheim GE. Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity. J Immunol 2017;199:2388-407. [PMID: 28848067 DOI: 10.4049/jimmunol.1601725] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
211 Puthenparampil M, Miante S, Federle L, Zanetta C, Toffanin E, Ruggero S, Rinaldi F, Gallo P. BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset. Journal of Neuroimmunology 2016;297:63-7. [DOI: 10.1016/j.jneuroim.2016.05.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
212 Matsuda Y, Imamura R, Takahara S. Evaluation of Antigen-Specific IgM and IgG Production during an In Vitro Peripheral Blood Mononuclear Cell Culture Assay. Front Immunol 2017;8:794. [PMID: 28740496 DOI: 10.3389/fimmu.2017.00794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
213 Alturaiki W. The roles of B cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) in allergic asthma. Immunol Lett 2020;225:25-30. [PMID: 32522667 DOI: 10.1016/j.imlet.2020.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 OʼLeary JG, Samaniego M, Barrio MC, Potena L, Zeevi A, Djamali A, Cozzi E. The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients. Transplantation 2016;100:39-53. [PMID: 26680372 DOI: 10.1097/TP.0000000000000869] [Cited by in Crossref: 73] [Cited by in F6Publishing: 21] [Article Influence: 12.2] [Reference Citation Analysis]
215 Prete M, Leone P, Frassanito MA, Desantis V, Marasco C, Cicco S, Dammacco F, Vacca A, Racanelli V. Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus. Lupus 2018;27:1926-35. [PMID: 30180771 DOI: 10.1177/0961203318797425] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
216 Thompson N, Isenberg DA, Jury EC, Ciurtin C. Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndrome. Rheumatology (Oxford) 2016;55:1548-55. [PMID: 26790457 DOI: 10.1093/rheumatology/kev420] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
217 Wang JZ, Zhang YH, Guo XH, Zhang HY, Zhang Y. The double-edge role of B cells in mediating antitumor T-cell immunity: Pharmacological strategies for cancer immunotherapy. Int Immunopharmacol 2016;36:73-85. [PMID: 27111515 DOI: 10.1016/j.intimp.2016.04.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
218 Ospina FE, Betancur JF, Suso JP, Muñoz-buitron E, Cañas CA, Tobón GJ. Role of the cytokine BAFF in autoimmune diseases: Physiopathology and therapeutic targets. Revista Colombiana de Reumatología (English Edition) 2016;23:177-94. [DOI: 10.1016/j.rcreue.2016.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
219 Nguyen T, Ahmed AR. Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin. Clin Exp Dermatol 2017;42:516-9. [DOI: 10.1111/ced.13092] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
220 Granja AG, Tafalla C. Different IgM+ B cell subpopulations residing within the peritoneal cavity of vaccinated rainbow trout are differently regulated by BAFF. Fish Shellfish Immunol 2019;85:9-17. [PMID: 28989090 DOI: 10.1016/j.fsi.2017.10.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
221 Radin M, Cecchi I, Schreiber K, Baldovino S, Rossi D, Menegatti E, Roccatello D, Sciascia S. Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus. Expert Opinion on Orphan Drugs 2016;5:55-69. [DOI: 10.1080/21678707.2017.1257937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
222 Kelsen JR, Sullivan KE, Rabizadeh S, Singh N, Snapper S, Elkadri A, Grossman AB. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Evaluation and Management for Patients With Very Early-onset Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;70:389-403. [PMID: 32079889 DOI: 10.1097/MPG.0000000000002567] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 19.0] [Reference Citation Analysis]
223 Vincent FB, Kandane-Rathnayake R, Koelmeyer R, Hoi AY, Harris J, Mackay F, Morand EF. Analysis of serum B cell-activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus. Clin Transl Immunology 2019;8:e01047. [PMID: 31024730 DOI: 10.1002/cti2.1047] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
224 Nezos A, Evangelopoulos ME, Mavragani CP. Genetic contributors and soluble mediators in prediction of autoimmune comorbidity. J Autoimmun 2019;104:102317. [PMID: 31444033 DOI: 10.1016/j.jaut.2019.102317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
225 Bornacelly A, Mercado D, Acevedo N, Caraballo L. The strength of the antibody response to the nematode Ascaris lumbricoides inversely correlates with levels of B-Cell Activating Factor (BAFF). BMC Immunol 2014;15:22. [PMID: 24906685 DOI: 10.1186/1471-2172-15-22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
226 Timlin H, Bingham CO 3rd. Efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritis. Expert Opin Biol Ther 2014;14:893-904. [PMID: 24720727 DOI: 10.1517/14712598.2014.900536] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
227 Wu H, Chen S, Li A, Shen K, Wang S, Wang S, Wu P, Luo W, Pan Q. LncRNA Expression Profiles in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets. Front Immunol 2021;12:792884. [PMID: 35003113 DOI: 10.3389/fimmu.2021.792884] [Reference Citation Analysis]
228 Matson EM, Abyazi ML, Bell KA, Hayes KM, Maglione PJ. B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease. Front Immunol 2020;11:622114. [PMID: 33613556 DOI: 10.3389/fimmu.2020.622114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Osório C, Chacón PJ, White M, Kisiswa L, Wyatt S, Rodríguez-Tébar A, Davies AM. Selective regulation of axonal growth from developing hippocampal neurons by tumor necrosis factor superfamily member APRIL. Mol Cell Neurosci 2014;59:24-36. [PMID: 24444792 DOI: 10.1016/j.mcn.2014.01.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
230 Isho B, Florescu A, Wang AA, Gommerman JL. Fantastic IgA plasma cells and where to find them. Immunol Rev 2021;303:119-37. [PMID: 34046908 DOI: 10.1111/imr.12980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]